BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31319193)

  • 1. Exploring the mechanism of PPARγ phosphorylation mediated by CDK5.
    Ribeiro Filho HV; Guerra JV; Cagliari R; Batista FAH; Le Maire A; Oliveira PSL; Figueira ACM
    J Struct Biol; 2019 Sep; 207(3):317-326. PubMed ID: 31319193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Recognition of PPARγ by Kinase Cdk5/p25: Insights from a Combination of Protein-Protein Docking and Adaptive Biasing Force Simulations.
    Mottin M; Souza PC; Skaf MS
    J Phys Chem B; 2015 Jul; 119(26):8330-9. PubMed ID: 26047365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into PPARγ Phosphorylation and Its Inhibition Mechanism.
    Montanari R; Capelli D; Yamamoto K; Awaishima H; Nishikata K; Barendregt A; Heck AJR; Loiodice F; Altieri F; Paiardini A; Grottesi A; Pirone L; Pedone E; Peiretti F; Brunel JM; Itoh T; Pochetti G
    J Med Chem; 2020 May; 63(9):4811-4823. PubMed ID: 32239932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand UHC1 blocks PPARγ phosphorylation by cyclin-dependent kinase 5 (CDK5) and improves insulin sensitivity.
    Choi SS; Kim ES; Koh M; Lee SJ; Lim D; Yang YR; Jang HJ; Seo KA; Min SH; Lee IH; Park SB; Suh PG; Choi JH
    J Biol Chem; 2014 Sep; 289(38):26618-26629. PubMed ID: 25100724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
    Choi JH; Banks AS; Estall JL; Kajimura S; Boström P; Laznik D; Ruas JL; Chalmers MJ; Kamenecka TM; Blüher M; Griffin PR; Spiegelman BM
    Nature; 2010 Jul; 466(7305):451-6. PubMed ID: 20651683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.
    Banks AS; McAllister FE; Camporez JP; Zushin PJ; Jurczak MJ; Laznik-Bogoslavski D; Shulman GI; Gygi SP; Spiegelman BM
    Nature; 2015 Jan; 517(7534):391-5. PubMed ID: 25409143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an ELISA for High-Throughput Screening of Inhibitors of Cdk5-Mediated PPARγ Phosphorylation.
    Prokoph N; Ormö M; O'Mahony G; Hogner A; McPheat J; Karlsson U; Holmberg Schiavone L; Liu J
    Assay Drug Dev Technol; 2016 May; 14(4):261-72. PubMed ID: 27027223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.
    Amato AA; Rajagopalan S; Lin JZ; Carvalho BM; Figueira AC; Lu J; Ayers SD; Mottin M; Silveira RL; Souza PC; Mourão RH; Saad MJ; Togashi M; Simeoni LA; Abdalla DS; Skaf MS; Polikparpov I; Lima MC; Galdino SL; Brennan RG; Baxter JD; Pitta IR; Webb P; Phillips KJ; Neves FA
    J Biol Chem; 2012 Aug; 287(33):28169-79. PubMed ID: 22584573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
    Quan Q; Qian Y; Li X; Li M
    J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the inhibitory effects of a novel reversible covalent ligand on PPARγ phosphorylation.
    Jang JY; Kim H; Kim HJ; Suh SW; Park SB; Han BW
    Sci Rep; 2019 Aug; 9(1):11168. PubMed ID: 31371757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes.
    Rai A; Tripathi S; Kushwaha R; Singh P; Srivastava P; Sanyal S; Bandyopadhyay S
    Cell Death Dis; 2014 Jan; 5(1):e1033. PubMed ID: 24481447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ.
    Ahn S; Jang DM; Park SC; An S; Shin J; Han BW; Noh M
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32054125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ S273 Phosphorylation Modifies the Dynamics of Coregulator Proteins Recruitment.
    Dias MMG; Batista FAH; Tittanegro TH; de Oliveira AG; Le Maire A; Torres FR; Filho HVR; Silveira LR; Figueira ACM
    Front Endocrinol (Lausanne); 2020; 11():561256. PubMed ID: 33329381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phloretin and phloridzin improve insulin sensitivity and enhance glucose uptake by subverting PPARγ/Cdk5 interaction in differentiated adipocytes.
    Kumar S; Sinha K; Sharma R; Purohit R; Padwad Y
    Exp Cell Res; 2019 Oct; 383(1):111480. PubMed ID: 31279631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ.
    Jang JY; Bae H; Lee YJ; Choi YI; Kim HJ; Park SB; Suh SW; Kim SW; Han BW
    Sci Rep; 2018 Jan; 8(1):31. PubMed ID: 29311579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient expression, purification and characterisation of human full-length PPARγ2 in HEK293 cells.
    Liu J; Ormö M; Nyström AC; Claesson J; Giordanetto F
    Protein Expr Purif; 2013 Jun; 89(2):189-95. PubMed ID: 23562662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation.
    Laghezza A; Piemontese L; Cerchia C; Montanari R; Capelli D; Giudici M; Crestani M; Tortorella P; Peiretti F; Pochetti G; Lavecchia A; Loiodice F
    J Med Chem; 2018 Sep; 61(18):8282-8298. PubMed ID: 30199253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex.
    Lemkul JA; Lewis SN; Bassaganya-Riera J; Bevan DR
    PLoS One; 2015; 10(5):e0123984. PubMed ID: 25954810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular expression of cyclin-dependent kinase 5 in patients with proliferative diabetic retinopathy.
    Sano H; Namekata K; Niki M; Semba K; Murao F; Harada T; Mitamura Y
    J Diabetes Investig; 2022 Apr; 13(4):628-637. PubMed ID: 34693664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
    Shiraki T; Kodama TS; Jingami H; Kamiya N
    Proteins; 2005 Feb; 58(2):418-25. PubMed ID: 15558556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.